Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial.
Inga JaroschTessa SchneebergerAntje StegemannRainer GloecklDaniela LeitlClancy DennisWolfgang HitzlChristopher SchoenAndreas Rembert KoczullaPublished in: Respiration; international review of thoracic diseases (2024)
Quantifiable subjective limitations of sleep have been revealed by PSG data in this PCS cohort. More than half of PCS patients had signs of sleep apnoea, highlighting the importance of sleep screening in PCS.
Keyphrases
- sleep quality
- physical activity
- end stage renal disease
- coronavirus disease
- sars cov
- ejection fraction
- chronic kidney disease
- clinical trial
- depressive symptoms
- randomized controlled trial
- study protocol
- prognostic factors
- electronic health record
- peritoneal dialysis
- big data
- patient reported outcomes
- phase ii
- phase iii
- respiratory syndrome coronavirus
- patient reported
- sleep apnea